NEWS4 December 2020
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
Insight & Strategy
Columnists
Impact magazine is a quarterly publication for MRS members. You can access Impact content on this website.
NEWS4 December 2020
US – Facebook will begin taking down posts spreading anti-vaccine conspiracy theories that have been debunked by public health experts.
In a blog post by Kang-Xing Jin, head of health at Facebook, the company confirmed it would work to stop the spread of misinformation about vaccines undermining Covid-19 vaccination programmes.
This includes any false claims about the safety, efficacy, ingredients and side-effects of the vaccines, Facebook said.
Facebook’s decision follows the announcement of several viable Covid-19 vaccines, with the UK having already authorised the use of the Pfizer/BioNTech vaccine, with a vaccination programme due to start next week.
The social media giant has in recent weeks announced several policies to combat the spread of misinformation through its platforms, having already issued restrictions on political advertising in the wake of last month’s US presidential election.
“We will remove false claims that Covid-19 vaccines contain microchips, or anything else that isn’t on the official vaccine ingredient list,” the blog post says.
“We will also remove conspiracy theories about Covid-19 vaccines that we know today are false: like specific populations are being used without their consent to test the vaccine’s safety.
“Since it’s early and facts about Covid-19 vaccines will continue to evolve, we will regularly update the claims we remove based on guidance from public health authorities as they learn more.”
The company said it would not be able to do this “overnight”, and did not provide a date for when it would start removing anti-vaccine content.
Newsletter
Sign up for the latest news and opinion.
You will be asked to create an account which also gives you free access to premium Impact content.
Businesses are investing in user experience research because they recognise that data is critical to building a suc… https://t.co/XCOErwBQ6F
Merkle hires ex-Accenture MD as EMEA chief sales officer https://t.co/frBI4XPSGv #mrx #marketresearch
LGBTQ+ inclusion in advertising survey reveals 'room for improvement' https://t.co/FCcPQIYLLf #mrx #marketresearch
The world's leading job site for research and insight
Hasson Associates
Associate Research Director
£40000–65000
Spalding Goobey Associates
Director – Technically Superb Quantitative Researcher – Strategic Insight Consultancy
£70 – 90,000 + Bens
Hasson Associates
Senior Research Manager / Associate Director
£300–300 per day
Featured company
Town/Country: London
Tel: +44 (0)20 7490 7888
Kudos Research are leading providers of premium quality UK and International Telephone Data-Collection. Specialising in hard to reach B2B and Consumer audiences, we achieve excellent response rates and provide robust, actionable, verbatim-rich data. Methodologies include CATI, . . .
Related Articles
Just like to say a big thumbs up to the lovely lady who did our document check @wandbc today . Cheerful helpful & a… https://t.co/ZxobUKtq0w
The post-demographic consumerism trend means segments such age are often outdated, from @trendwatching #TrendSemLON
0 Comments